Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion to sirolimus in renal transplant recipients with cutaneous squamous cell carcinoma
2005-004372-20Phase 4Completed
- Sponsor
- Oxford University Hospitals
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in cutaneous squamous cell carcinoma (cSCC) and Kidney allograft status (RTx) (2 arms), sponsored by Oxford University Hospitals. Primary endpoint: Recurrence of cutaneous squamous cell carcinoma. Started Nov 2005; status: completed.
02
Drugs
sirolimus
03
Conditions
cutaneous squamous cell carcinoma (cSCC)Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2005-004372-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004372-20.